01 1Dasami Lab
01 1ESLICARBAZEPINE ACETATE (PROCESS-II)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-03-08
Pay. Date : 2020-12-29
DMF Number : 35472
Submission : 2021-02-16
Status : Active
Type : II
20
Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ESLICARBAZEPINE ACETATE (PROCESS-II), with a corresponding US DMF Number 35472.
Remarkably, this DMF maintains an Active status since its submission on February 16, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 08, 2021, and payment made on December 29, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
